Only one dose of the vaccine, developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID) in the United States, was needed. “This study shows that delivering the vaccine directly to the respiratory tract can effectively protect primates from SARS,” said Dr Brian Murphy, a co-chief of the NIAID Laboratory of Infectious Diseases.

“With more research, we hope to develop a vaccine based on this approach that could be used to rapidly immunize first responders and other medical personnel, helping them control a potential outbreak,” he added in a statement. Continue reading →